Cargando…

Cellular Host Responses to Gliomas

BACKGROUND: Glioblastoma multiforme (GBM) is the most aggressive type of malignant primary brain tumors in adults. Molecular and genetic analysis has advanced our understanding of glioma biology, however mapping the cellular composition of the tumor microenvironment is crucial for understanding the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Najbauer, Joseph, Huszthy, Peter C., Barish, Michael E., Garcia, Elizabeth, Metz, Marianne Z., Myers, Sarah M., Gutova, Margarita, Frank, Richard T., Miletic, Hrvoje, Kendall, Stephen E., Glackin, Carlotta A., Bjerkvig, Rolf, Aboody, Karen S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335155/ https://www.ncbi.nlm.nih.gov/pubmed/22539956 http://dx.doi.org/10.1371/journal.pone.0035150

Ejemplares similares

Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung Cancer
por: Gutova, Margarita, et al.
Publicado: (2007)

Iron Labeling and Pre-Clinical MRI Visualization of Therapeutic Human Neural Stem Cells in a Murine Glioma Model
por: Thu, Mya S., et al.
Publicado: (2009)

Neural Stem Cells as a Novel Platform for Tumor-Specific Delivery of Therapeutic Antibodies
por: Frank, Richard T., et al.
Publicado: (2009)

Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression
por: Huszthy, Peter C., et al.
Publicado: (2015)

Correction: Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression
por: Huszthy, Peter C., et al.
Publicado: (2015)

Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects
por: Hossain, Jubayer A, et al.
Publicado: (2020)

Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model
por: Barish, Michael E., et al.
Publicado: (2017)

Remission of Invasive, Cancer Stem-Like Glioblastoma Xenografts Using Lentiviral Vector-Mediated Suicide Gene Therapy
por: Huszthy, Peter C., et al.
Publicado: (2009)

Quantitative Evaluation of Intraventricular Delivery of Therapeutic Neural Stem Cells to Orthotopic Glioma
por: Gutova, Margarita, et al.
Publicado: (2019)

Long-term stability and computational analysis of migration patterns of L-MYC immortalized neural stem cells in the brain
por: Rockne, Russell C., et al.
Publicado: (2018)

Planarians as a model of aging to study the interaction between stem cells and senescent cells in vivo
por: Perrigue, Patrick M., et al.
Publicado: (2015)

GMP Production and Scale-Up of Adherent Neural Stem Cells with a Quantum Cell Expansion System
por: Tirughana, Revathiswari, et al.
Publicado: (2018)

In vivo models of primary brain tumors: pitfalls and perspectives
por: Huszthy, Peter C., et al.
Publicado: (2012)

Development of a Tumor-Selective Approach to Treat Metastatic Cancer
por: Aboody, Karen S., et al.
Publicado: (2006)

Contact and Encirclement of Glioma Cells In Vitro Is an Intrinsic Behavior of a Clonal Human Neural Stem Cell Line
por: Khosh, Nousha, et al.
Publicado: (2012)

Concise Review: Stem Cells As an Emerging Platform for Antibody Therapy of Cancer
por: Frank, Richard T, et al.
Publicado: (2010)

A reproducible brain tumour model established from human glioblastoma biopsies
por: Wang, Jian, et al.
Publicado: (2009)

L-MYC Expression Maintains Self-Renewal and Prolongs Multipotency of Primary Human Neural Stem Cells
por: Li, Zhongqi, et al.
Publicado: (2016)

Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma
por: Gutova, Margarita, et al.
Publicado: (2012)

Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes
por: Exner, Nadin D., et al.
Publicado: (2019)

Early Changes in Tumor Perfusion from T1-Weighted Dynamic Contrast-Enhanced MRI following Neural Stem Cell-Mediated Therapy of Recurrent High-Grade Glioma Correlate with Overall Survival
por: Sahoo, Prativa, et al.
Publicado: (2018)

Stem Cell‐based therapies for COVID‐19‐related acute respiratory distress syndrome
por: Ngai, Hoi Wa, et al.
Publicado: (2022)

Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
por: Andersen, Johannes K., et al.
Publicado: (2022)

Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction
por: Morshed, Ramin A., et al.
Publicado: (2014)

Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma
por: Gutova, Margarita, et al.
Publicado: (2016)

Therapeutic Effect of Cabazitaxel and Blood-Brain Barrier opening in a Patient-Derived Glioblastoma Model
por: Sulheim, Einar, et al.
Publicado: (2019)

iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype
por: Rajcevic, Uros, et al.
Publicado: (2009)

TWIST1 associates with NF-κB subunit RELA via carboxyl-terminal WR domain to promote cell autonomous invasion through IL8 production
por: Li, Shan, et al.
Publicado: (2012)

Expansive growth of two glioblastoma stem-like cell lines is mediated by bFGF and not by EGF
por: Podergajs, Neza, et al.
Publicado: (2013)

Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients
por: Portnow, Jana, et al.
Publicado: (2021)

A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1
por: Klink, Barbara, et al.
Publicado: (2013)

Correction: A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1
por: Klink, Barbara, et al.
Publicado: (2013)

Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma
por: Wang, Jian, et al.
Publicado: (2011)

Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells
por: Podergajs, Neža, et al.
Publicado: (2015)

PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1
por: Ji, Jianxiong, et al.
Publicado: (2019)

Role of CEACAM1, ECM, and Mesenchymal Stem Cells in an Orthotopic Model of Human Breast Cancer
por: Samineni, Sridhar, et al.
Publicado: (2011)

Erratum of “Role of CEACAM1, ECM, and Mesenchymal Stem Cells in an Orthotopic Model of Human Breast Cancer”
por: Samineni, Sridhar, et al.
Publicado: (2011)

Intranasally Administered L-Myc-Immortalized Human Neural Stem Cells Migrate to Primary and Distal Sites of Damage after Cortical Impact and Enhance Spatial Learning
por: Gutova, Margarita, et al.
Publicado: (2021)

Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy
por: Zhu, Huaiyang, et al.
Publicado: (2017)

Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling
por: Han, Mingzhi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eo3q5moq0fpja54aqlui5q673n